Unicycive Therapeutics (UNCY) Short Interest Ratio & Short Volume → Wall Street Legend Warns: 'A Strange Day Is Coming to America' (From Chaikin Analytics) (Ad) Free UNCY Stock Alerts $0.84 -0.11 (-11.59%) (As of 05/28/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Unicycive Therapeutics Short Interest DataCurrent Short Interest859,800 sharesPrevious Short Interest575,000 sharesChange Vs. Previous Month+49.53%Dollar Volume Sold Short$928,584.00Short Interest Ratio2.3 Days to CoverLast Record DateMay 15, 2024Outstanding Shares37,610,000 sharesFloat Size27,090,000 sharesShort Percent of Float3.17%Today's Trading Volume1,278,821 sharesAverage Trading Volume355,621 sharesToday's Volume Vs. Average360% Short Selling Unicycive Therapeutics ? Sign up to receive the latest short interest report for Unicycive Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartUNCY Short Interest Over TimeUNCY Days to Cover Over TimeUNCY Percentage of Float Shorted Over Time Ad Chaikin AnalyticsWall Street Legend Warns: "A Strange Day Is Coming to America"Get Your Cash Out of U.S. Banks Immediately Man who predicted 2023 bank run warns a historic financial reset is coming. Get out of cash and into a new vehicle 50 years in the making.Click here to learn more. Unicycive Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/2024859,800 shares $928,584.00 +49.5%3.2%2.3 $1.08 4/30/2024575,000 shares $644,000.00 +50.2%2.1%1.4 $1.12 4/15/2024382,900 shares $436,506.00 +49.1%1.5%1 $1.14 3/31/2024256,800 shares $354,384.00 +352.9%1.0%0.7 $1.38 3/15/202456,700 shares $82,782.00 +62.0%0.2%0.2 $1.46 2/29/202435,000 shares $48,300.00 -64.3%0.1%0.1 $1.38 Get the Latest News and Ratings for UNCY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Unicycive Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/15/202498,000 shares $128,380.00 +46.7%0.4%0.4 $1.31 1/31/202466,800 shares $63,460.00 -2.8%0.3%0.3 $0.95 1/15/202468,700 shares $57,708.00 -20.9%0.3%0.4 $0.84 12/31/202386,900 shares $75,403.13 +1.5%N/A0 $0.87 12/15/202385,600 shares $48,988.88 +65.6%0.3%0.9 $0.57 11/30/202351,700 shares $26,496.25 -30.0%0.2%0.7 $0.51 11/15/202373,900 shares $38,620.14 +18.6%0.3%1.4 $0.52 10/31/202362,300 shares $35,529.69 -42.7%0.3%1.2 $0.57 10/15/2023108,800 shares $93,350.40 -25.4%0.4%1.9 $0.86 9/30/2023145,800 shares $125,388.00 +34.5%0.6%2.4 $0.86 9/15/2023108,400 shares $75,045.32 +71.3%0.4%1.1 $0.69 8/31/202363,300 shares $48,291.57 -21.0%0.5%0.6 $0.76 8/15/202380,100 shares $60,876.00 -53.9%0.6%0.6 $0.76 7/31/2023173,800 shares $203,346.00 -16.0%3.2%1.1 $1.17 7/15/2023206,900 shares $254,487.00 -15.8%3.8%1 $1.23 6/30/2023245,800 shares $314,624.00 -10.3%2.7%1 $1.28 6/15/2023274,100 shares $433,078.00 +8.8%3.0%0.9 $1.58 5/31/2023252,000 shares $332,640.00 -13.6%2.7%0.1 $1.32 5/15/2023291,800 shares $417,274.00 +21.7%3.2%0.1 $1.43 4/30/2023239,700 shares $311,610.00 -8.0%2.6%0 $1.30 4/15/2023260,400 shares $460,908.00 -34.7%2.9%0 $1.77 3/31/2023398,700 shares $837,270.00 -71.3%4.4%0.1 $2.10 3/15/20231,390,000 shares $3.07 million +839.2%15.3%0.2 $2.21 2/28/2023148,000 shares $76,516.00 -17.9%1.6%0 $0.52 2/15/2023180,300 shares $100,968.00 +55.3%2.0%0.6 $0.56 1/31/2023116,100 shares $65,016.00 -40.6%1.3%0.4 $0.56 1/15/2023195,600 shares $97,311.00 -24.5%2.2%0.8 $0.50 12/30/2022259,000 shares $139,860.00 +284.3%2.9%1.1 $0.54 12/15/202267,400 shares $47,510.26 +18.5%0.7%2 $0.70 11/30/202256,900 shares $40,524.18 +4.8%0.6%2 $0.71 11/15/202254,300 shares $38,010.00 +35.8%0.6%2 $0.70 10/31/202240,000 shares $27,600.00 -7.4%0.4%1.6 $0.69 10/15/202243,200 shares $24,619.68 +7.2%0.5%1.3 $0.57 9/30/202240,300 shares $23,777.00 +53.2%0.4%1.2 $0.59Wall Street Legend Warns: "A Strange Day Is Coming to America" (Ad)Get Your Cash Out of U.S. Banks Immediately Man who predicted 2023 bank run warns a historic financial reset is coming. Get out of cash and into a new vehicle 50 years in the making.Click here to learn more. 9/15/202226,300 shares $19,988.00 -36.0%0.3%0.8 $0.76 8/31/202241,100 shares $28,770.00 +21.2%0.5%1.2 $0.70 8/15/202233,900 shares $23,736.78 -62.1%0.4%0.9 $0.70 7/31/202289,500 shares $66,230.00 +54.6%1.0%2.4 $0.74 7/15/202257,900 shares $46,348.95 -29.6%0.6%1.9 $0.80 6/30/202282,200 shares $68,226.00 -12.7%0.9%2.5 $0.83 6/15/202294,200 shares $97,026.00 +17.3%1.0%2.5 $1.03 5/31/202280,300 shares $71,467.00 +49.0%0.9%1.3 $0.89 5/15/202253,900 shares $37,730.00 -39.4%0.6%0.7 $0.70 4/30/202288,900 shares $77,405.23 +1.5%1.0%1.1 $0.87 4/15/202287,600 shares $94,608.00 -35.1%1.0%0.7 $1.08 3/31/2022134,900 shares $174,021.00 +185.8%1.5%0.9 $1.29 3/15/202247,200 shares $50,504.00 -49.3%0.5%0.3 $1.07 2/28/202293,100 shares $129,409.00 -22.2%1.0%0.6 $1.39 2/15/2022119,600 shares $160,264.00 +51.8%1.3%0.7 $1.34 1/31/202278,800 shares $108,744.00 -49.9%0.9%0.4 $1.38 1/15/2022157,300 shares $281,567.00 +112.6%1.7%1 $1.79 12/31/202174,000 shares $152,440.00 +74.5%0.8%0.5 $2.06 12/15/202142,400 shares $95,824.00 -35.0%0.5%0.3 $2.26 11/30/202165,200 shares $139,528.00 -7.8%0.7%0.4 $2.14 11/15/202170,700 shares $188,062.00 -34.9%0.8%0.4 $2.66 10/29/2021108,600 shares $313,854.00 +1.5%1.3%0.6 $2.89 10/15/2021107,000 shares $291,040.00 +14.2%1.3%0.3 $2.72 9/30/202193,700 shares $265,171.00 +564.5%1.1%0.1 $2.83 9/15/202114,100 shares $41,031.00 -78.3%0.2%0 $2.91 8/31/202165,100 shares $188,790.00 +25.9%0.8%0 $2.90 8/13/202151,700 shares $141,141.00 No Change0.6%0 $2.73 UNCY Short Interest - Frequently Asked Questions What is Unicycive Therapeutics' current short interest? Short interest is the volume of Unicycive Therapeutics shares that have been sold short but have not yet been closed out or covered. As of May 15th, traders have sold 859,800 shares of UNCY short. 3.17% of Unicycive Therapeutics' shares are currently sold short. Learn More on Unicycive Therapeutics' current short interest. What is a good short interest ratio for Unicycive Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. UNCY shares currently have a short interest ratio of 2.0. Learn More on Unicycive Therapeutics's short interest ratio. What is a good short interest percentage for Unicycive Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.17% of Unicycive Therapeutics' floating shares are currently sold short. Is Unicycive Therapeutics' short interest increasing or decreasing? Unicycive Therapeutics saw a increase in short interest in May. As of May 15th, there was short interest totaling 859,800 shares, an increase of 49.5% from the previous total of 575,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Unicycive Therapeutics' float size? Unicycive Therapeutics currently has issued a total of 37,610,000 shares. Some of Unicycive Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Unicycive Therapeutics currently has a public float of 27,090,000 shares. How does Unicycive Therapeutics' short interest compare to its competitors? 3.17% of Unicycive Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Unicycive Therapeutics: Lexaria Bioscience Corp. (1.40%), VYNE Therapeutics Inc. (0.46%), Jaguar Health, Inc. (4.32%), Fortress Biotech, Inc. (11.49%), Eyenovia, Inc. (10.27%), DURECT Co. (3.13%), Reviva Pharmaceuticals Holdings, Inc. (6.38%), Cara Therapeutics, Inc. (5.23%), NRx Pharmaceuticals, Inc. (7.00%), CASI Pharmaceuticals, Inc. (0.83%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short Unicycive Therapeutics stock? Short selling UNCY is an investing strategy that aims to generate trading profit from Unicycive Therapeutics as its price is falling. UNCY shares are trading down $0.08 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Unicycive Therapeutics? A short squeeze for Unicycive Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of UNCY, which in turn drives the price of the stock up even further. How often is Unicycive Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including UNCY, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Lexaria Bioscience Short Interest VYNE Therapeutics Short Interest Jaguar Health Short Interest Fortress Biotech Short Interest Eyenovia Short Interest DURECT Short Interest Reviva Pharmaceuticals Short Interest Cara Therapeutics Short Interest NRx Pharmaceuticals Short Interest CASI Pharmaceuticals Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:UNCY) was last updated on 5/28/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”Timothy SykesElon’s New Device is About to Shock the WorldInvestorPlaceExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsThe #1 Crypto for AIWeiss RatingsThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaDigitizing the $11T commodities sector with one tiny stockResource Stock DigestMusk, Bezos, and Gates All On Board… Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Unicycive Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.